Xu Donghang, Ph.D.

Position:Executive Vice Chair of Pharmacy


Medical School:Zhejiang University School of Medicine, China

Academic Rank:Chief Pharmacist

Clinical / Research Interests

Hospital pharmacy, sustained and/or controlled release, clinical pharmacokinetics, pharmacogenomics, molecular pharmaceutics. 

Professional Highlights

Professional Appointments

Senior Member, Chinese Pharmaceutical Association 

Member, Chinese Pharmacological Association 

Education Experience

Research Summary

Dr. Xu has published more than 80 research articles or reviews, including 5 SCI papers as first author or corresponding author.


Xu DH, et al. Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance. Pharm Dev Technol. 2020 Oct 18:1-9. (Correspond author)

Xu DH, et al. Reduced Toxicity of Liposomal Nitrogen Mustard Prodrug Formulation Activated by an Intracellular ROS Feedback Mechanism in Hematological Neoplasm Models. Mol Pharm. 2020 Feb 3;17(2):499-506. (Correspond author)

Xu DH, et al. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells. Drug Dev Ind Pharm. 2019 Sep;45(9):1556-1564. (Correspond author)

Current Program

Find People

Search by Family Name

Find A Department

Search by Departments